[Experience in the therapeutic use of methylandrostenediole in patients with myocardial dystrophy and atherosclerotic cardiosclerosis].
D045930:Anabolic Agents / Q000627:therapeutic use*; D003327:Coronary Disease / Q000150:complications*; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications*
D045930:Anabolic Agents
Opyt lechebnogo primeniia metialandrostendiola u bol'nykh s distrofieĭ miokarda i arteroskleroticheskim kardiosklerozom.